SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
+31.2%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$1.14B
AUM Growth
+$1.14B
(+26%)
Cap. Flow
-$178M
Cap. Flow
% of AUM
-15.61%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
104
New
30
Increased
28
Reduced
25
Closed
13
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
$43.7M |
| 2 |
TG Therapeutics
TGTX
|
$38.3M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$23.2M |
| 4 |
Keros Therapeutics
KROS
|
$18.1M |
| 5 |
Biogen
BIIB
|
$15.7M |
Top Sells
| 1 |
Jasper Therapeutics
JSPR
|
$255M |
| 2 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
$46.4M |
| 3 |
GSK
GSK
|
$41.1M |
| 4 |
Viking Therapeutics
VKTX
|
$30.3M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$29.3M |
Sector Composition
| 1 | Healthcare | 99.93% |
| 2 | Consumer Staples | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Xenon Pharmaceuticals
XENE
$2.98B
| – | – | -58,000 | Closed | -$2.67M |
|
|
RYZB
102
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| – | – | -746,622 | Closed | -$46.4M |
|
|
IMGN
103
DELISTED
Immunogen Inc
IMGN
| – | – | -13,050 | Closed | -$387K |
|
|
HARP
104
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| – | – | -820,638 | Closed | -$9.33M |
|